Clinical Trial Update: Pioglitazone for the Treatment of Bipolar Depression [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating pioglitazone for bipolar depression was terminated. Results were posted on 2017-01-27.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Insulin Resistance

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Bipolar Disorder, Insulin Resistance | Phase 4 | Status: TERMINATED | Results posted: 2017-01-27